FDA OKs AstraZenaca’s Tagrisso for Lung Cancer

… specific type of non-small cell lung cancer. Tagrisso (80mg once-daily tablets) was … (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an … EGFR T790M mutation-positive non-small cell lung cancer. This indication is approved under …